Russia has developed a drug to combat antibiotic-resistant bacteria
Russian scientists have developed a drug designed to fight antibiotic-resistant bacteria, including Klebsiella pneumoniae. This was announced by Alexander Gintsburg, Scientific Director of the Gamaleya National Research Center for Epidemiology and Microbiology (NITSEM) of the Ministry of Health of the Russian Federation.
"We have a drug called Fluorothiazinone. Now it is a drug that overcomes antibiotic resistance, because Klebsiella pneumoniae is not terrible in itself, the strains that are resistant to antibiotics are terrible. Therefore, Fluorothiazinone <...> overcomes this resistance," he said in an interview with RIA Novosti.
According to the scientist, the medicine has already helped hundreds of patients with severe infectious complications. In particular, it is actively used at the Herzen Moscow Cancer Research Institute.
Ginzburg clarified that the specialists conducted additional clinical studies to expand the indications for the use of the drug. The relevant documents have already been sent to the Ministry of Health of the Russian Federation, where an expert assessment of the possibility of wider use of the drug is expected.
On November 18, Politico newspaper reported an increase in the number of cases of infection with the antibiotic-resistant bacterium Klebsiella pneumoniae in European hospitals. According to the ECDC report, from 2019 to 2025, the number of cases of blood poisoning caused by this bacterium increased by 72%. Later, the World Health Organization noted that the risk of further spread of Klebsiella pneumoniae in Europe is real.
Переведено сервисом «Яндекс Переводчик»